Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
CBC
Support for Students with Disabilities
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
Program Resources
You are here
Home
>
Multiple sclerosis journal - experimental, translational and clinical
Multiple sclerosis journal - experimental, translational and clinical
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
